TodayLegal News

Verdict.News

All Topics

Merger And Acquisition

Legal news related to Merger And Acquisition

6 articles

State Court
•4 min read
Delaware Supreme Court

Delaware Supreme Court Issues Split Decision in J&J-Auris Health Case

The Delaware Supreme Court issued a mixed ruling in a dispute between Johnson & Johnson and former Auris Health stockholders over the pharmaceutical giant's 2019 acquisition of the surgical robotics company. The court affirmed some aspects of the lower court's decision while reversing others and remanding portions of the case.

•Delaware Supreme Court affirmed in part, reversed in part, and remanded case between J&J and former Auris Health stockholders
•Dispute centers on post-closing earnout provisions from J&J's acquisition of medical robotics company Auris Health
AI-generated SummaryRead Article →
Regulatory
•4 min read

FTC Sues to Block $725M Henkel-Liquid Nails Construction Adhesive Merger

The Federal Trade Commission filed a lawsuit to block Henkel AG's $725 million acquisition of Liquid Nails, citing concerns that combining the two dominant construction adhesive brands would eliminate competition and drive up costs for American consumers building and maintaining homes.

•FTC seeks to block $725 million acquisition of Liquid Nails by Henkel, maker of Loctite brand adhesives
•Combined company would dominate construction adhesive market at major retailers like Home Depot and Lowe's
AI-generated SummaryRead Article →
Regulatory
•4 min read

Aya Healthcare Drops Cross Country Merger After FTC Antitrust Concerns

Aya Healthcare terminated its proposed acquisition of Cross Country Healthcare after the Federal Trade Commission raised significant competitive concerns. The FTC warned the merger would eliminate competition between two major healthcare staffing firms and potentially increase costs for hospitals and patients.

•FTC identified competitive concerns that would eliminate head-to-head competition between two largest healthcare staffing firms
•Merger termination protects options for thousands of healthcare workers and prevents hospital cost increases
AI-generated SummaryRead Article →
Regulatory
•4 min read

FTC Orders Divestiture of 45 Oil Change Shops in $625M Valvoline Deal

The Federal Trade Commission is requiring Valvoline Inc. and Greenbriar Equity Fund V to divest 45 quick-lube oil change shops to address antitrust concerns in their $625 million acquisition deal. The divestiture aims to preserve competition and prevent higher prices for consumers across eight states.

•FTC requires divestiture of 45 Oil Changers outlets to Main Street Auto LLC as condition for Valvoline's $625 million acquisition of 200 quick-lube shops
•Antitrust concerns focused on elimination of competition in 25 local markets across eight states where companies directly compete
AI-generated SummaryRead Article →
Regulatory
•4 min read

FTC Approves $13.5B Omnicom-IPG Merger With Ban on Political Ad Boycotts

The Federal Trade Commission approved a final consent order allowing Omnicom Group's $13.5 billion acquisition of Interpublic Group to proceed, but with strict conditions preventing the merged entity from denying advertising dollars to media publishers based on political or ideological viewpoints.

•FTC approves $13.5 billion Omnicom-IPG merger with modified consent order after public comment period
•Final order prohibits denying advertising dollars to media publishers based on political or ideological viewpoints
AI-generated SummaryRead Article →
Regulatory
•4 min read

FTC Blocks Edwards Lifesciences' $945M Heart Device Deal

The Federal Trade Commission filed suit to block Edwards Lifesciences' proposed $945 million acquisition of JenaValve Technology, alleging the deal would create a monopoly in the market for transcatheter aortic valve replacement devices used to treat aortic regurgitation. The FTC argues that combining the only two companies with ongoing U.S. clinical trials for these life-saving heart devices would stifle innovation and increase costs for patients.

•Edwards acquired JC Medical in July 2024 and seeks to buy JenaValve for $945 million, combining the only two companies with ongoing U.S. clinical trials for TAVR-AR devices
•More than 8 million Americans suffer from aortic regurgitation, currently treatable only through invasive open heart surgery
AI-generated SummaryRead Article →